Publication | Closed Access
S1066 Oral Alpha-4 Integrin Inhibitor (AJM300) in Patients with Active Crohn's Disease — A Randomized, Double-Blind, Placebo-Controlled Trial
54
Citations
0
References
2009
Year
InflammationA RandomizedGastrointestinal PharmacologyActive CrohnImmunologyGastroenterologyPlacebo-controlled TrialMedicineInflammatory DiseaseDigestive System Diseases
No additional data available for this publication yet. Check back later!